Spero Therapeutics Inc. (SPRO)
NASDAQ: SPRO
· Real-Time Price · USD
1.90
0.01 (0.53%)
At close: Sep 29, 2025, 3:59 PM
1.93
1.52%
After-hours: Sep 29, 2025, 06:54 PM EDT
0.53% (1D)
| Bid | 1.87 |
| Market Cap | 106.92M |
| Revenue (ttm) | 40.5M |
| Net Income (ttm) | -54.47M |
| EPS (ttm) | -0.98 |
| PE Ratio (ttm) | -1.94 |
| Forward PE | -47.25 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 2.19 |
| Volume | 154,790 |
| Avg. Volume (20D) | 626,752 |
| Open | 1.89 |
| Previous Close | 1.89 |
| Day's Range | 1.88 - 1.93 |
| 52-Week Range | 0.51 - 3.22 |
| Beta | 1.46 |
| Ex-Dividend Date | n/a |
About SPRO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SPRO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SPRO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-17.8%
Spero Therapeutics shares are trading lower follow...
Unlock content with
Pro Subscription
2 months ago
-1.36%
Shares of several biotechnology stocks are trading higher amid Vinay Prasad's departure as director of the FDA's Center for Biologics Evaluation and Research.
